BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2019.
World J Hepatol. Feb 27, 2019; 11(2): 208-216
Published online Feb 27, 2019. doi: 10.4254/wjh.v11.i2.208
Table 1 Clinical and demographic data at time of liver transplant listing and short-term clinical outcome of patients with and without central line-associated bloodstream infection
No CLABSICLABSIP value
n (%)44 (70)19 (30)
Male, n (%)11 (25)5 (26)0.91
Race, n (%)
White38 (86)15 (79)0.71
Black5 (11)3 (16)
Asian1 (2)1 (5)
Ethnicity, n (%)
Hispanic25 (57%)9 (47%)0.49
Primary language non-English, n (%)12 (27)3 (16)0.32
Insurance, n (%)0.036
Public/none25 (57)16 (84)
Private19 (43)3 (16)
Kasai portoenterostomy timing, n (%)0.99
≤ 100 d28 (64)12 (63)
> 100 d2 (5)1 (5)
Not performed14 (32)6 (32)
Age at listing, years, mean (SD)0.59 (0.27)0.61 (0.31)0.89
Any home parenteral nutrition, n (%)16 (36)9 (47)0.41
Anthropometrics
Length, cm, mean (SD)64.5 (3.8)64.3 (3.6)0.82
Weight, kg, mean (SD)6.9 (1.3)6.6 (1.1)0.38
Length z-score, mean (SD)-1.26 (1.47)-1.57 (1.24)0.43
Weight z-score, mean (SD)-0.96 (1.26)-1.44 (0.98)0.15
WFL z-score, mean (SD)-0.21 (1.13)-0.58 (0.91)0.21
Laboratory
ALT, U/L, median (25th, 75th)133 (90, 204)128 (90, 233)0.98
GGT, U/L, median (25th, 75th)257 (106, 504)364 (205, 800)0.14
Albumin, g/dL, mean (SD)3.1 (0.46)3 (0.68)0.88
Conjugated bilirubin, mg/dL, median (25th, 75th)4.2 (0.95, 8.2)3.7 (2, 5.7)0.73
Total bilirubin, mg/dL, median (25th, 75th)10.7 (3.5, 16.2)11.3 (6.2, 12.7)0.90
White blood cells, × 103/µL, median (25th, 75th)10.2 (8.3, 15.6)10.6 (7.4, 14.4)0.88
Hemoglobin, g/dL, mean (SD)9.9 (1.6)10.2 (1.3)0.56
Platelets, × 103/µL, median (25th, 75th)123 (95, 217)160 (102, 230)0.41
INR, mean (SD)1.6 (0.6)2.3 (4.1)0.28
BUN, mg/dL, mean (SD)9.5 (5)9.9 (4.6)0.73
Prealbumin, mg/dL, mean (SD)9.5 (3.6)9.5 (4.3)0.95
Clinical outcome0.29
Transplanted35 (80)18 (95)
Died on the waitlist or removed for too ill6 (14)1 (5)
Removed from waitlist for too well3 (7)0


Write to the Help Desk